Pabau Engage inbox

Pabau Engage is here: every patient conversation in one inbox.

Learn more
Book a demo Book a demo
☰
Practice Management Tips

HCPCS Code Q4163: Woundex and BioSkin billing guide

Avatar photo Anja Dodevska
Last Updated: November 20, 2026

HCPCS Code Q4163 is the Level II code for Woundex and BioSkin, a dehydrated human amniotic membrane allograft billed per square centimeter. It is an add-on code, so it is billed only alongside a skin substitute application procedure. From January 1, 2026, Medicare pays it as an incident-to supply at $127.14 per sq cm. CMS confirmed that figure in its November 2025 fee schedule correction.

That rate applies in the physician office and the hospital outpatient department alike, with no geographic adjustment. This guide covers the descriptor, 2026 payment by setting, units, modifiers, ICD-10 pairings and documentation. It closes with the denials that follow when one is missing.

Key takeaways

Key takeaways

HCPCS Code Q4163 reports one named product, Woundex or BioSkin, per sq cm. It is not a catch-all code for unlisted skin substitutes.

Q4163 is an add-on code. It is billed only together with an application procedure from the 15271–15278 range on the same claim.

In 2026 Medicare pays $127.14 per sq cm as an incident-to supply, in both the office and the hospital outpatient department, with no GPCI adjustment.

Hospital outpatient departments bill Q4163 separately in APC 6002, the group for 361 HCT/P products such as amniotic membrane allografts.

Wound measurements, product details and the treatment history must be recorded for every application date, or the claim is hard to defend.

Found our content helpful?

HCPCS Code Q4163: Official descriptor and product classification

HCPCS Code Q4163 is a product-specific code in the Q-series of skin substitute codes that CMS maintains. CMS added it on January 1, 2016, and it remains active in 2026. Each code in the series names one product or product family, and Q4163 names Woundex and BioSkin sheets.

FieldDetail
CodeQ4163
Code systemHCPCS Level II (Q-series skin substitutes)
Official descriptorWoundex, bioskin, per square centimeter (add-on, list separately in addition to primary procedure)
ProductWoundex or BioSkin, a dehydrated human amniotic membrane allograft supplied as a sheet
FDA category361 HCT/P (human cell and tissue product regulated under Section 361 of the Public Health Service Act)
Unit of measurePer square centimeter (sq cm) of product
Code addedJanuary 1, 2016; active in 2026
Code typeAdd-on: billed only with an application procedure code (15271–15278) on the same claim

Bill Q4163 only when the product applied is Woundex or BioSkin. A different skin substitute is reported with its own Q-code or A-code, never with Q4163. The residual code for unlisted products, Q4100 (“Skin substitute, not otherwise specified”), was terminated on December 31, 2025.

Q4163 vs neighboring skin substitute codes

Two codes cause most mix-ups with Q4163. One is the flowable version of the same product line, and the other is the retired catch-all code that older claims and templates still carry.

CodeDescriptorHow it differs from Q4163
Q4163Woundex, bioskin, per square centimeterSheet form, billed per sq cm as an add-on to the application procedure
Q4162Woundex flow, bioskin flow, 0.5 ccFlowable form of the same product line, billed per 0.5 cc, not per sq cm
Q4100Skin substitute, not otherwise specifiedTerminated December 31, 2025, so it cannot be billed for 2026 dates of service

Check the invoice before coding. If the product arrived as a vial of flowable material, Q4162 is the code, and the units follow volume, not wound area. If a claim template still defaults to Q4100 for amniotic grafts, retire it, because those lines will now reject.

How to bill HCPCS Code Q4163: Step-by-step guidelines

A clean Q4163 claim pairs the product code with an application procedure, the correct units, any modifiers the MAC requires and a covered diagnosis. Understanding medical billing fundamentals provides the foundation, and the steps below add the parts specific to skin substitutes.

  1. Measure the wound: Record length, width and depth in centimeters on the date of service, before the product is applied.
  2. Record the product used: Note the product name, sheet size, lot number and the sq cm applied. Note any amount discarded as well.
  3. Choose the application procedure: Select the code from 15271–15278 that matches the wound site and the total wound area (see the table below).
  4. Set the units: Bill Q4163 in sq cm of product, following your MAC’s instructions for applied and discarded product.
  5. Apply required modifiers: Append laterality and any LCD-specific modifiers (see the modifier section below).
  6. Link the diagnosis: Point Q4163 and the application procedure to a covered ICD-10-CM code that names the wound type, site and severity.

Application procedures billed with Q4163

The application procedure depends on where the wound is and how large the total wound area is. Q4163 cannot stand on a claim without one of these primary procedures.

CodesWound siteTotal wound area
15271 / 15272Trunk, arms, legsUp to 100 sq cm: first 25 sq cm, then each additional 25 sq cm
15273 / 15274Trunk, arms, legs100 sq cm or more: first 100 sq cm, then each additional 100 sq cm (or 1% of body area in infants and children)
15275 / 15276Face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, multiple digitsUp to 100 sq cm: first 25 sq cm, then each additional 25 sq cm
15277 / 15278Face, scalp, eyelids, mouth, neck, ears, orbits, genitalia, hands, feet, multiple digits100 sq cm or more: first 100 sq cm, then each additional 100 sq cm (or 1% of body area in infants and children)

Most diabetic foot ulcers fall under 15275, because the foot is in the second site group. Most venous leg ulcers fall under 15271. The application code describes the wound area, while Q4163 units describe the product, so the two numbers rarely match.

Required modifiers for Q4163

Modifier requirements for HCPCS Code Q4163 are largely MAC-specific, but several apply broadly across payers. The table below covers the most common ones and the situations that trigger them.

ModifierWhen to useCommon error
RT / LTWound is on a paired body part (right foot, left leg)Omitting laterality on foot and ankle wounds, which triggers a denial
KXCertifies that the LCD medical necessity criteria are met (required by some MACs)Leaving KX off when the MAC requires it, so the line denies
GAA signed ABN is on file for a service expected to be denied as not reasonable and necessaryAppending GA when no ABN was signed, which leaves the practice liable
GYThe service is statutorily excluded from Medicare benefitsUsing GY where GA applies, so the wrong liability rules follow

Supported ICD-10 diagnosis codes for Q4163

Every Q4163 claim needs at least one ICD-10-CM code from the LCD’s covered-diagnosis list. The code must match the wound type, site and laterality written in the record. Diagnoses missing from that list cause a large share of skin substitute denials.

Wound categoryRepresentative ICD-10-CM codesNotes
Diabetic foot ulcerE10.621, E11.621Type 1 (E10) or type 2 (E11) diabetes with foot ulcer. Add an L97.4- or L97.5- code for the ulcer’s site and depth.
Venous leg ulcerI87.311, I87.312, I87.313, I87.319Chronic venous hypertension with ulcer: right, left, bilateral or unspecified. Add an L97 code for site and depth.
Pressure injuryL89.011–L89.014 (right elbow, stages 1–4)Each site has its own stage 1–4 codes. L89.019 is unspecified stage, so code the documented stage instead.
Non-healing surgical woundT81.30XA, T81.31XA, T81.32XADisruption of wound closure. Use the encounter character (A, D or S) that fits the visit.
Non-pressure chronic ulcerL97.111–L97.929 seriesLower-limb ulcers by site, laterality and depth. The sixth character records severity.

Cross-reference each code against the controlling MAC’s LCD before you submit. The CMS HCPCS code reference publishes the official descriptor, while each LCD lists the diagnoses that support coverage in its jurisdiction.

Medicare coverage and eligibility criteria for Q4163

Medicare Part B covers HCPCS Code Q4163 for wound care indications set out in the Local Coverage Determinations of each Medicare Administrative Contractor (MAC). Each claim must show medical necessity against those criteria. A non-covered use is denied, and the practice cannot bill the patient unless a signed Advance Beneficiary Notice (ABN) is on file.

Covered indications are chronic wounds that have failed conventional care over a defined period. The wound types most often covered by MAC skin substitute LCDs are:

  • Diabetic foot ulcers with at least four weeks of documented standard care before the first application
  • Venous leg ulcers with at least four weeks of documented compression therapy before the first application
  • Pressure injuries (stages 2–4) with documented offloading and conservative treatment
  • Surgical wounds with dehiscence where conservative management has not achieved closure

Non-covered uses include acute traumatic wounds without prior conservative treatment, cosmetic applications and wounds that fall short of the LCD’s minimum treatment period.

Local Coverage Determinations that govern Q4163

Each MAC publishes its own skin substitute policy, and the clinical criteria, documentation rules and covered diagnoses vary by jurisdiction. The A/B MACs include CGS Administrators (Jurisdiction 15) and Noridian Healthcare Solutions (Jurisdictions E and F). Palmetto GBA covers Jurisdictions J and M, and First Coast Service Options covers Jurisdiction N.

To find the controlling LCD for a patient, search the CMS Medicare Coverage Database by the MAC jurisdiction. LCD numbers and effective dates change when policies are revised, so check them at the start of each billing period.

Prior authorization requirements

Original Medicare does not generally require prior authorization for Q4163, but skin substitute claims face prepayment and post-payment review. Medicare Advantage plans set their own rules, and many require prior authorization for skin substitutes. Confirm the requirement with the patient’s plan before the first application.

Pro Tip

Check Medicare Advantage prior authorization before the application date, not after it. A denial for a missing authorization is very hard to overturn once the graft is on. Record the authorization number and approval date in the patient record the day you receive them.

Q4163 fee schedule and reimbursement in 2026

From January 1, 2026, Medicare pays Q4163 as an incident-to supply at one national rate of $127.14 per sq cm. CMS finalized it in the CY 2026 Physician Fee Schedule final rule (CMS-1832-F). The CMS correction notice to the CY 2026 Physician Fee Schedule final rule set the figure at $127.14. The CY 2026 OPPS final rule applies the same rate in hospital outpatient departments.

The rate carries no GPCI adjustment, so a practice in Manhattan and one in rural Kansas receive the same amount per sq cm. Only skin substitutes licensed as biologics under Section 351 (BLA products) stay on ASP plus 6%. Q4163 is a 361 HCT/P, so the flat rate applies.

SettingHow Q4163 is paid in 2026Who bills Q4163Key note
Physician office (POS 11)Incident-to supply at $127.14 per sq cmThe practice, on the CMS-1500The practice buys the product and bills it with the application procedure.
Hospital outpatient department (POS 22 or 19)Paid separately under OPPS in APC 6002 at $127.14 per sq cmThe hospital, on the UB-04The physician bills the application procedure only. Q4163 on the professional claim would duplicate the hospital’s charge.

Hospital outpatient departments now pay skin substitutes in new APCs grouped by FDA category. APC 6000 holds PMA products, APC 6001 holds 510(k) products and APC 6002 holds 361 HCT/P products. Woundex and BioSkin are amniotic membrane allografts regulated as 361 HCT/Ps, so Q4163 falls in APC 6002.

Before 2026, office payment for the product was based on its average sales price or set by the MAC. It was never a GPCI-adjusted fee schedule rate. Budgets built on 2025 remittances for Q4163 will need resetting to the flat 2026 figure.

Common claim denials for Q4163 and how to prevent them

Q4163 claims face close review because skin substitutes are a high-cost, high-audit category. Effective denial management workflows start with the Claim Adjustment Reason Code (CARC) on the remittance, because each CARC points to a specific fix.

Denial reasonCommon CARCPrevention action
Missing wound measurementsCARC 16 or 50Record wound dimensions in cm on the date of service, at every application
Diagnosis not on the LCD covered listCARC 11 or 50Check the diagnosis against the MAC’s LCD before each claim
No record of prior standard careCARC 50Keep the four-week standard-of-care record with the first-application claim
Units not supported by the recordCARC 151Match units to the sq cm of product recorded in the procedure note
Q4163 billed without an application procedureCARC 107Bill Q4163 on the same claim as the 15271–15278 application code
Modifier missing or invalidCARC 4Apply RT or LT for paired body parts, and confirm the MAC’s KX rule
Prior authorization absent (Medicare Advantage)CARC 197Verify authorization with the plan before the date of service
Wrong product codePayer-specificBill Q4163 only when the invoice names Woundex or BioSkin sheets

A consistent pre-submission checklist prevents most of these. Mapping each of the denial codes in medical billing to the record it needs keeps first-pass acceptance high.

Appealing a Q4163 denial

A Medicare redetermination must be filed within 120 days of receiving the initial determination. Build the appeal around the LCD criterion the denial cites, and attach the evidence for it:

  • The procedure note with wound measurements and the sq cm of Woundex or BioSkin applied
  • The four-week standard-of-care record that preceded the first application
  • Dated wound photographs that show the wound’s response between applications
  • The product invoice and lot number, which tie the units billed to the product used

Documentation requirements to support Q4163 claims

Documentation failures cause more Q4163 denials than coding errors. The Wound, Ostomy and Continence Nurses Society (WOCN) tools and MAC LCDs agree on the core elements: each application date needs its own complete entry. Denials often hit dates where the chart held the facts, but not in a form the reviewer could find.

Medical billing compliance for skin substitute claims depends on recording these elements for each application:

  • Wound dimensions: length, width and depth in centimeters, measured on the date of service
  • Wound characteristics: wound bed (granulation, eschar, slough), exudate, periwound skin and any signs of infection
  • Prior treatment history: at least four weeks of standard care (debridement, dressings, offloading or compression) before the first application
  • Product details: Woundex or BioSkin by name, sheet size, lot number, sq cm applied and any amount discarded
  • Physician order and care plan: a signed order naming the product, with goals, frequency and criteria for stopping
  • Patient response: progress notes showing whether the wound is shrinking or failing to respond
  • ABN, if applicable: a signed ABN on file where the service may not be covered

Pro Tip

Attach a dated wound photograph to the note for every application. Many MACs accept photographs as supporting evidence in audits and appeals. A visible reduction in wound size strengthens the medical necessity case at redetermination.

How Pabau supports Q4163 billing

Q4163 claims fail when the procedure note, the product record and the claim are kept in three places. A coder then rebuilds the units and the graft details from memory, and the numbers drift.

Pabau, a practice management platform with built-in claims management, keeps those records together. Stock carries a batch number, and the lot is recorded against the patient and the appointment. US practices submit CMS-1500 claims through the Claim.MD clearinghouse, check eligibility and post ERA remittances against the same record.

Prior authorization codes, dates and sessions are tracked on the patient’s case, with a warning when one is missing. That matters for Medicare Advantage patients, whose plans often require authorization before the first application.

Pabau claims management screen showing a submitted claim and its payment status
Pabau’s claims management shows each submitted claim and its status, so your team can follow a Q4163 line from submission to payment.

Keep your skin substitute claims moving

Pabau’s claims management helps US practices submit CMS-1500 claims through Claim.MD, check eligibility and post remittances against the patient record. See how it fits your wound care billing.

Pabau claims management dashboard

Conclusion

Q4163 is a narrow code with a simple 2026 price. It names one product, it rides on an application procedure, and Medicare pays $127.14 per sq cm wherever the graft goes on. The risk has moved from the rate to the record.

A claim now stands or falls on whether the note proves the product, the area and the four weeks of care before it. Practices that capture those at the bedside will spend less time on appeals. Book a demo to see how Pabau keeps wound records and claims in one workflow.

Continue your research

Continue your research

Need a foundation for wound care claim compliance? Clean claim submission breaks down what makes a claim pass on first submission and where skin substitute claims most often fail.

Scaling billing across a multi-provider wound care practice? Skin clinic software covers the operational workflow features that wound care and dermatology practices use to manage documentation, billing, and compliance in one platform.

Frequently asked questions

What is HCPCS Code Q4163 used for?

HCPCS Code Q4163 reports Woundex or BioSkin, a dehydrated human amniotic membrane allograft, per square centimeter. It is used on chronic wounds such as diabetic foot ulcers and venous leg ulcers. It is billed as an add-on to a skin substitute application procedure.

Is Q4163 a not otherwise specified skin substitute code?

No. Q4163 is a product-specific code for Woundex and BioSkin, added on January 1, 2016. The not otherwise specified code was Q4100, which CMS terminated on December 31, 2025.

What is the Medicare reimbursement rate for Q4163 in 2026?

Medicare pays Q4163 at $127.14 per square centimeter in 2026, as an incident-to supply. The same national rate applies in the physician office and the hospital outpatient department, with no geographic adjustment. Hospitals bill it in APC 6002.

Does Medicare cover HCPCS Code Q4163?

Yes, when the wound meets the clinical criteria in the MAC’s Local Coverage Determination. That usually means a documented chronic wound, at least four weeks of standard care and measurements on every date of service.

Which procedure codes are billed with Q4163?

Q4163 is billed with an application procedure from 15271–15278. The choice depends on the wound site and whether the total wound area is under or over 100 square centimeters.

Is prior authorization required for Q4163?

Original Medicare does not generally require prior authorization for Q4163, though claims face prepayment and post-payment review. Many Medicare Advantage plans require it, so verify with the patient’s plan before the first application.

What modifiers are used with HCPCS Code Q4163?

The most common are RT or LT for laterality and KX where the MAC requires certification that LCD criteria are met. GA applies when a signed ABN is on file, and GY when the service is statutorily excluded.

Found our content helpful?
Avatar photo
Anja Dodevska
Content Writer

Anja Dodevska writes about healthcare, dermatology, and the day-to-day realities of running a medical practice for Pabau. She enjoys breaking down complex topics into clear, accessible content and has a soft spot for the often-overlooked aspects of clinic life. When she's not writing, she's exploring cafes, walking her dog, or spending time with friends and family.
×